Basic fibroblast growth factor (FGF-2), an important modulator of cartilage and bone growth and differentiation, is expressed and regulated in osteoblastic cells. To investigate the role of FGF-2 in bone, we examined mice with a disruption of the Fgf2 gene. Measurement of trabecular bone architecture of the femoral metaphysis of Fgf2 +/+ and Fgf2 -/-adult mice by micro-CT revealed that the platelike trabecular structures were markedly reduced and many of the connecting rods of trabecular bone were lost in the Fgf2 -/-mice. Dynamic histomorphometry confirmed a significant decrease in trabecular bone volume, mineral apposition, and bone formation rates. In addition, there was a profound decreased mineralization of bone marrow stromal cultures from Fgf2 -/-mice. This study provides strong evidence that FGF-2 helps determine bone mass as well as bone formation.
Introduction
Basic fibroblast growth factor (FGF-2) influences the proliferation and differentiation of a variety of cell types in vitro (1) (2) (3) (4) (5) . It is stored in the extracellular matrix (ECM) (3, 6, 7) and is expressed in osteoblasts (7) . FGF-2 has been shown to be an important modulator of cartilage and bone cell function (2, (8) (9) (10) . Previously, we reported that overexpression of FGF-2 in transgenic mice resulted in achondroplasia and shortening of the long bones (11) . Fibroblast growth factor receptors (FGFRs) are also important regulators of bone growth and development and are differentially expressed in bone and cartilage (2, 12, 13) . A number of human dysmorphic syndromes have been genetically linked to mutations in different FGFRs (2, 14, 15) . Disruption of the FGFR3 gene in mice resulted in increased endochondral bone growth (16, 17) , whereas mutations in FGFR2 increased expression of osteoblast differentiation markers in calvarial osteoblasts (18) . FGFR2 is essential for limb bud initiation, and loss of FGFR1 results in distal truncation of mouse limb bud (19) .
In bone cell cultures, FGF-2 stimulated replication (20) and reduced differentiation markers such as alkaline phosphatase and type 1 collagen (21) (22) (23) (24) . In contrast to continuous treatment, intermittent FGF-2 treatment stimulated bone formation in vitro (23) and in vivo (2, 25) . In vivo studies in rats have consistently shown that FGF-2 stimulated new bone formation on endosteal and trabecular bone surfaces but not on periosteal surfaces (25) (26) (27) . Several groups have reported on the anabolic effect of FGF-2 to restore bone mass in ovariectomized (OVX) rats (28) (29) (30) , a well-established model for postmenopausal bone loss. FGF-2 not only stimulated bone formation on preexisting bone surfaces, but also induced de novo formation of bone spicules within the marrow cavity, resulting in partial restoration of the loss of cancellous bone mass in the osteopenic OVX rats (30) . That FGF-2 treatment increased cancellous bone in the marrow cavity (25, 30) suggests that osteoblast precursors in the marrow cavity are a target cells for the effects of FGF-2. This observation is important, as bone marrow contains osteoblast precursors/stromal cells that synthesize FGF-2 (31) and responds to FGF-2 in an autocrine/paracrine manner (32) (33) (34) (35) . FGFs also play an important role in fracture repair in rats (36) and in humans (37) . The Fgf2 gene is expressed at an early stage of fracture repair in granulation tissue at the fracture site (38) . FGF-2 is also a potent stimulator of osteoclast formation and bone resorption (5, 39, 40) . Thus, FGF-2 should be considered as an important regulator of osteoclastic-osteoblastic interaction or coupling.
FGF-2 is expressed in osteoblasts (20, (41) (42) (43) , osteocytes, and periosteal cells (42) . Fgf2 mRNA and protein levels are increased in osteoblasts by transforming growth factor β (41), prostaglandins (42) , and parathy-roid hormone (43) . Thus, hormones and local factors, which have important functions in bone homeostasis, regulate FGF-2 production.
These data demonstrate that FGF signaling plays important roles in bone development. Because there are at least 17 FGFs besides FGF-2, many of which have multiple receptor specificities ( [44] [45] [46] [47] [48] [49] [50] , it is important to determine which ligands play specific roles in skeletogenesis. Recently, Fgf2 -/-mice were developed in a Black Swiss ×129 Sv genetic background (51) . These mice are viable and reproduce. Fgf2 -/-mice have decreased vascular smooth muscle contractility, low blood pressure, and thrombocytosis. They also have a diminished response to IL-3. a cytokine that stimulates hematopoietic multilineage proliferation and differentiation (52) . Fgf2 -/-mice were shown to have delayed wound healing (53) and neuronal defects and impaired development of the cerebral cortex (53, 54) .
Because FGF-2 has profound effects on osteoblast replication and differentiation, we examined the effect that deletion of the Fgf2 gene had on bone formation. This study provides strong evidence that FGF-2 is an important determinant of bone mass and is a regulator of bone formation.
Methods
Mice were bred and housed in the transgenic facility in the center for laboratory animal care at the University of Connecticut Health Center. Mice were sacrificed by CO 2 narcosis and cervical dislocation. Animal protocols were approved by the Animal Care Committee of the University of Connecticut Health Center.
Cell replication. Osteoblastic cells populations of 2-5 cells that are a mixture of preosteoblasts, osteoblasts, and osteocytes were prepared from the calvariae of 8-week-old Fgf2 +/+ and Fgf2 -/-mice by sequential digestion with 0.1% collagenase (Boehringer Mannhiem Biochemicals Inc., Indianapolis, Indiana, USA) and plated in 100-mm dishes in DMEM with 10% heat inactivated FCS (Hyclone Laboratories, Logan, Utah, USA) for 12 days in a 5% CO 2 incubator at 37°C. Cells were replated at a density of 5,000 cells/cm 2 for 7 days with media change every 3 days. For labeling studies, [ 3 H]thymidine (10 µCi/well) was added for the last 4 hours of the culture to measure cell proliferation (20) .
Bone marrow stromal cultures. Cells were isolated as described previously (55) . Briefly, tibiae and femur from 6-month-old Fgf2 +/+ and Fgf2 -/-mice were dissected free of adhering tissue. The ends were removed, and the marrow cavity was flushed with α-MEM (GIBCO-BRL, Grand Island, New York, USA). Cells were plated at 2 × 10 6 cells/well, unless stated otherwise, in 6-multiwell plates in αMEM containing 10% FCS; cultures were fed every 3 days with fresh differentiation media (αMEM, 10 nM dexamethasone, 10% FCS, 8 mM β-glycerophosphate, 50 µg/mL ascorbic acid). Cells were fixed and stained for alkaline phosphatase using a commercially available kit (Sigma Chemical Co., St. Louis, Missouri, USA). Colony number and area was determined by NIH Image (version 1.61; National Institutes of Health, Bethesda, Maryland, USA). Some dishes were then restained with von Kossa reagent to determine mineralization.
Measurement of mRNA levels. Osteoblastic cells were prepared from calvariae of 8-week-old Fgf2 +/+ and Fgf2 -/-mice as already described here. Second-passage cells were plated at 5,000 cells/cm 2 in DMEM with FCS (10%); ascorbic acid (50 µg/mL), and β-glycerophosphate (8 mM) for 7-21 days. Total RNA was extracted from cells by the method of Chomczynski and Sacchi (56) . For Northern analysis, 20 µg of total RNA was denatured and fractionated on a 0.8% agarose/1.1 M formaldehyde gel, transferred to filters by capillary blotting or positive pressure, and fixed to the filter by ultraviolet irradiation (Stratalinker; Stratagene, La Jolla, California, USA) (57) . After a 4-hour prehybridization, filters were hybridized overnight with a [ 32 P]-labeled mouse cDNA probe for either Fgf1 or Fgf2 (58) .
Bone histomorphometry. Fgf2 -/-mice appeared normal and had no significant size or weight differences compared with Fgf2 +/+ mice. Fgf2 +/+ and Fgf2 -/-mice at 4.5 months or 8 months of age were weighed and injected on day 1 with calcein at 0.6 mg/100 g body weight; a second injection was administered on day 5; and mice were sacrificed on day 8. The right proximal tibiae were fixed with 10% buffered formalin followed by 100% ethanol, then embedded in methyl methacrylate (MMA), Five-micrometer-thick midfrontal sections of the proximal tibiae were obtained using a Reichert microtome (Reichert-Jung, Heidelburg, Germany). The left proximal tibiae were fixed with 4% paraformaldehyde and embedded in a mixture of MMA, hydroxyglyucol methacrylate, and 2-hydroxyethylacrylate. Polymerization was performed at 4°C. Then, undecalcified 5-µm sections were stained for tartrate-resistant acid phosphatase (TRAP) (59) .
Histomorphometry was performed with a semiautomatic image-analyzing system linked to a light microscope (Cosmozone 1S; Nikon, Tokyo, Japan). The area of the secondary spongiosa was analyzed excluding the region within 0.5 mm of the growth plate-metaphyseal junction (60) . The tibial metaphyseal cancellous bone area 4.5 mm distal to the growth plate-metaphyseal junction was analyzed. Trabecular bone volume density (BV/TV, %), was measured, and the trabecular thickness (Tb.Th, µm) and trabecular number (Tb.N, mm -1 ) were calculated by the parallel plate method of Parfitt et al. (61) . The Tb.N was defined as the number of intersections between bone and nonbone components per total length of test lines applied to a specimen (62) . Osteoclast surface (Oc.S/BS, %) and osteoclast number (Oc.N/BS, mm) were determined. Oc.N/BS, mm were TRAP-positive cells that formed resorption lacunae at the surface of the trabeculae and contained more than 1 nuclei that were identified as osteoclasts. For dynamic histomorphometry, mineralizing surface (DLS/BS, %), mineral apposition rate (MAR, µm/d), and bone formation rate (BFR/BS, µm 3 /µm 2 per day) were also measured. (2) and is stored in the bone matrix (3), we determined whether it was expressed in osteoblasts from Fgf2 -/-mice. Northern analysis showed no Fgf1 mRNA transcript in osteoblasts of either genotype. However, Fgf1 mRNA was expressed in brain tissue from Fgf2 +/+ mice, which was used as a positive control (data not shown).
Results

FGF mRNA expression in calvarial osteoblasts from
Effect of disruption of the Fgf2 gene on bone cell replication. We measured thymidine incorporation into DNA in calvarial osteoblasts from 8-week-old Fgf2 +/+ and Fgf2 -/-mice. Thymidine incorporation into DNA was significantly reduced by 69% in calvarial osteoblast cultures from Fgf2 -/-mice ( Figure 2) . We compared the ability of 24-hour treatment with exogenous FGF-2 to increase cell replication in these cultures. The addition of FGF-2 (10 nM) increased cell replication in osteoblasts from both genotypes.
Alkaline phosphatase-positive colonies and mineralized nodules in bone marrow cultures of Fgf2 +/+ and Fgf2 -/-mice. We assessed whether disruption of the Fgf2 gene would alter the formation of alkaline phosphatase-positive (ALP) colonies and mineralized nodules in bone marrow cultures from Fgf2 -/-mice. Bone marrow cells were plated at a low density 1 × 10 6 cells per well in the absence and presence of FGF-2 (10 nM), which was added for the first 3 days of the 14-day culture period. The number of ALP colonies were counted and colony area was measured using NIH Image (version 1.61). Comparison of vehicle-treated bone marrow cultures from both genotypes showed fewer ALP colonies (29 + 4 vs. 16 + 0.8; P < 0.05) and decreased colony area (0.24 + 0.05 vs. 0.07 + 0.01; P < 0.05) in bone marrow cultures from Fgf2 -/-mice. The effect of FGF-2 treatment on colony area is shown in Figure 3a . There was a significant increase in colony area in response to FGF-2 treatment. However,
Figure 1
Northern analysis for Fgf2 mRNA expression in primary calvarial osteoblasts prepared from 7-day-old Fgf2 +/+ and Fgf2 -/-mice. Total RNA was extracted from cells after 7, 9, 14, and 21 days of culture. A 6-kb Fgf2 mRNA transcript was expressed in calvarial osteoblast cultures from Fgf2 +/+ mice (lanes 1, 3, 5, and 7). No Fgf2 mRNA transcript was detected in osteoblasts from Fgf2 -/-mice (lanes 2, 4, 6, and 8).
Figure 2
Comparison of thymidine incorporation into DNA in calvarial osteoblasts from 8-week-old Fgf2 +/+ and Fgf2 -/-mice. Osteoblastic cells were prepared from calvariae of 8-week-old Fgf2 +/+ and Fgf2 -/-mice and plated in 100-mm dishes in DMEM with 10% heat inactivated FCS for 12 days. Cells were harvested and replated at a density of 5,000 cells/cm 2 for 7 days. Media were changed every 3 days. Cultures were treated with fresh media in the absence or presence of FGF-2 (10 nM) for the last 24 hours of the culture period. For labeling studies, [ 3 H]thymidine (10 µCi/well) was added for the last 4 hours of the culture to measure thymidine incorporation into DNA. Values are the mean ± SEM for 6 determinations per group. A Significantly different from control cultures; P < 0.05. B Significantly different from Fgf2 +/+ ; P < 0.05. colony area remained reduced in the bone marrow cultures of Fgf2 -/-mice compared with the response to FGF-2 treatment in bone marrow cultures from Fgf2 +/+ mice. In some experiments, bone marrow cells were plated at 20 6 cells per well and cultured for 13 or 21 days, stained for ALP, and then restained for mineral by the von Kossa method (Figure 3b) . In these cultures, we were unable to count discrete ALP colonies in cultures from Fgf2 +/+ because of the diffuse staining; however, even at such high initial plating densities, discrete colonies were seen in bone marrow cultures of the Fgf2 -/-mice. There were fewer ALP colonies after 13 days and minimal staining for mineral after 20 days in the bone marrow cultures of Fgf2 -/-mice compared with Fgf2 +/+ cultures (Figure 3b) .
Micro-CT analysis of trabecular bone of the distal metaphysis of the femur of 4.5-month adult Fgf2 +/+ and Fgf2 -/-mice. We examined bone microarchitecture in adult mice of both genotypes by micro-CT (63) . Threedimensional images of the femoral metaphysis of 4.5-month-old male Fgf2 +/+ and Fgf2 -/-mice are shown in (Figure 4) . The platelike structure of the trabecular bone was markedly reduced, and the connecting rods of trabeculae were disrupted in Fgf2 -/-mice compared with Fgf2 +/+ mice ( Figure 4 ). Using 2-dimensional images, total area, bone area, and bone perimeter were determined from which the BV/TV, Tb.Th, Tb.N, and Tb.Sp were calculated. Figure 5 shows that the calculated 3-dimensional parameters. BV/TV and Tb.N were significantly decreased by 34% and 31%, respectively, and Tb.Sp was significantly increased by 63% in Fgf2 -/-mice compared with Fgf2 +/+ mice. Tb.Th was not different between the 2 genotypes at this age (data not shown).
Static and dynamic histomorphometric analysis of tibiae of 4.5-month Fgf2 +/+ and Fgf2 -/-mice. Static histomorphometric analysis of the right proximal tibiae of 4.5-month-old mice confirmed the micro-CT findings. Structural parameters of bone volume and trabecular number were significantly reduced and trabecular separation was significantly increased in Fgf2 -/-mice compared with Fgf2 +/+ mice ( Table 1) . As with micro-CT, trabecular thickness was unchanged (data not shown). Parameters of bone resorption were determined using the left proximal tibiae. Osteoclast surface and osteoclast number were reduced in Fgf2 -/-bones, but the differences did not achieve statistical significance.
To determine whether the decrease in bone mass was due to a decrease in bone formation dynamic, histomorphometric parameters of bone formation were determined. Quantification of bone formation in the right proximal tibiae is shown in Table 2 . Doublelabeled surface, mineral apposition rate, and bone formation rate were all significantly reduced in Fgf2 -/-mice. These data are consistent with low turnover state in Fgf2 -/-bones compared with Fgf2 +/+ bones and suggest that there is a marked defect in osteoblast proliferation and differentiation in Fgf2 -/-mice. 
Histomorphometry of the distal femurs of 8-month-old Fgf2 +/+ and Fgf2 -/-mice. We also examined undecalcified sections of the distal femurs of 8-month-old male
Micro-CT analysis of trabecular bone of the distal metaphysis of the femurs of 8-month-old Fgf2 +/+ and Fgf2 -/-mice.
We examined bone microarchitecture in 8-month-old mice of both genotypes by micro-CT. Table 3 shows that the calculated 3-dimensional parameters of BV/TV and Tb.N were significantly decreased by 67% and 54%, respectively, and Tb.Sp was significantly increased by 249% in bones from the Fgf2 -/-mice compared with Fgf2 +/+ mice. In contrast to our observation in the 4.5-month-old mice, Tb.Th was decreased by 27% in bones from these older Fgf2 -/-mice.
Static histomorphometric analysis of tibiae of 8-month-old Fgf2 +/+ and Fgf2 -/-mice. We performed static histomorphometric analysis of the right proximal tibiae of 8-month-old mice. As shown in Table 4 , structural parameters of bone volume and trabecular number were significantly reduced and trabecular separation was significantly increased in Fgf2 -/-mice compared with Fgf2 +/+ mice. These data confirm the micro-CT results obtained from the distal femora of 8-month-old Fgf2 -/-mice as shown in Table 3 . Parameters of bone resorption were determined in the left proximal tibia. In these older mice, osteoclast surface was reduced by 48% in Fgf2 -/-, but osteoclast number was not significantly decreased.
Discussion
We hypothesized that disruption of the Fgf2 gene, might result in decreased bone formation, as FGF-2 is a potent mitogen for osteoblasts and osteoblast precursors (20, 2) as well as a stimulator of bone formation (2, (25) (26) (27) (28) (29) (30) . Furthermore, FGF-2 is differentially expressed in the growth plate of long bones during the process of endochondral bone formation (64) . Cross-sectional immunohistochemical studies of 18 day rat fetuses showed that FGF-2 staining was present in chondrocytes in the early stages of differentiation (64) . The centers of ossification, calcified matrix, and osteoblasts also contained intense staining for FGF-2 (64). Other studies examined Fgf2 mRNA and protein by in situ hybridization and immunohistochemistry, respectively, and showed expression in resting and proliferative chondrocytes of the epiphyseal growth plate of human fetus (65) . In earlier studies, bone marrow stromal cells were shown to synthesize and release FGF-2 (31) and to proliferate in response to FGF-2. These studies suggested a possible role for Fgf2 in endochondral bone formation.
In this report, we show that proliferation was decreased in calvarial osteoblastic cells derived from 8-week-old Fgf2 -/-mice. As shown in Figure 2 , at the end of 7 days of culture, thymidine labeling was significantly reduced in the Fgf2 -/-calvarial osteoblast cultures compared with Fgf2 +/+ calvarial osteoblast cultures. Thus, endogenous FGF-2 appears to be important in maintaining the basal rate of osteoblast replication. The addition of exogenous FGF-2 to the calvarial osteoblast cultures of both genotypes induced a mitogenic response. However, administration of recombinant FGF-2 (the 18-kDa isoform) did not completely restore the proliferative response in calvarial osteoblast cultures from the Fgf2 -/-mice. We also found that bone marrow stromal cells from Fgf2 -/-mice formed fewer ALP mineralized colonies (Figure 3b) . These results could be due to a decrease in osteoblast precursor number, secondary to decreased replication. We conducted experiments to determine whether short-term addition of exogenous FGF-2 to bone marrow cultures from Fgf2 +/+ and Fgf2 -/-mice would increase the number of ALP colonies and colony area. The ALP colony formation defect in bone marrow cultures of the Fgf2 -/-mice was only partially restored by recombinant 18-kDa FGF-2 treatment (Figure 3a) . These results are interesting, as several studies suggest that specific isoforms of FGF-2 may differentially modulate cell phenotype (66, 67) .
In mouse bones, there are 3 isoforms of FGF-2 protein with molecular weights (MWs) of 18, 21, and 22 kDa. We confirmed in our previous report that deletion of the FGF-2 gene abrogated all isoforms of FGF-2 protein (51). Studies have shown that cells expressing only the low molecular wt (LMW; 18 kDa) FGF-2 isoform were more migratory than cells expressing only the higher molecular wt (HMW) forms (66, 67) . Previous studies have demonstrated that the 18-kDa FGF-2 is primarily localized to the cytoplasm, whereas the HMW proteins are localized to the nucleus and may be important in mediating the mitogenic response (66) . In an earlier study, we examined the growth of smooth muscle cells from transgenic mice overexpressing LMW, HMW, or all MW isoforms of FGF-2 (67) . We demonstrated that serum-stimulated growth was highest in cultured smooth cells expressing the HMW hFGF-2 isoforms, intermediate in cells with the non-nuclear LMW isoform, and lowest in wild-type cells. Furthermore, neutralizing anti-FGF-2 antibody markedly decreased serum stimulated DNA synthesis, but only in the cell lines overexpressing the exported/non-nuclear LMW isoform (67) . These studies suggest an important role for the nuclear forms of FGF-2 in the mitogenic response to this growth factor. Therefore, it is possibly that in the absence of the HMW isoforms, treatment with LMW FGF-2 cannot completely rescue the proliferation defect that we observed in the calvarial osteoblast cultures or the ALP colony formation defect in bone marrow stromal cell cultures from Fgf2 -/-mice. Currently, the HMW proteins are not available to determine whether addition of these proteins would fully restore these responses.
Bone marrow stroma is a complex tissue that contains pluripotent cells capable of differentiating into a variety of mesenchymal cell types (68, 69) including osteoblasts, which can differentiate and express alkaline phosphatase, type I collagen, and osteocalcin and produce a mineralizable matrix (69) (70) (71) . Rat bone marrow stromal culture models have been used to demonstrate in vivo, the stimulatory effect of FGF-2 on bone formation (72) (73) (74) . In vitro studies, using human bone marrow stromal cells, have shown that FGF-2 modulates the growth and expression of the osteogenic phenotype of human bone marrow-derived bonelike cells (75) (76) (77) (78) . As shown in a representative experiment in Figure 3b , there were fewer ALP, mineralized colonies formed in the bone marrow cultures from the Fgf2 -/-mice. It is possible that in the absence of FGF-2, a factor(s) that promotes osteoblast differentiation is reduced or absent. Studies have shown that FGF-2 can synergize with plateletderived growth factor to maintain the osteogenic potential of rat marrow-derived mesenchymal cells (79) . In addition, the combination of FGF-2 and bone morphogenic protein-2 was more potent than either factor alone in inducing new bone formation in rats (80) .
Osteoblasts and adipocytes develop from multipotent mesenchymal stem cells of the bone marrow (81) , and previous studies have shown that defective osteoblastogenesis and osteopenia in mice can be associated with increased adipogenesis and myelopoeisis (82) . Because FGF-2 promotes development of other bone marrow lineage by affecting stromal cells and early committed hematopoetic progenitors (83), we examined the effect of disruption of the Fgf2 gene on hematopoetic bone marrow lineage in our previous publication (51) . Methylcellulose culture of bone marrow cells revealed a decrease in hematopoetic colony formation in the Fgf2 -/-mice, and increased number of megakaryocytes. Studies to examine adipogenesis in bone marrow cultures of the Fgf2 -/-mice are planned.
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Figure 5
Three-dimensional microstructural parameters calculated using 2-dimensional data obtained from micro-CT of femoral bones from 4. The micro-CT data (Figures 4 and 5) and the static and dynamic histomorphometric studies in the 4.5-month-old Fgf2 -/-mice (Tables 1 and 2 ) demonstrated a marked decrease in bone mass and a decreased rate of new bone formation that were quite consistent with each other. Increased trabecular separation was also found in the femora of 4.5-month-old Fgf2 -/-mice. Dark-field examination of undecalcified distal femoral bones of older, 8-month-old Fgf2 +/+ (Figure 6a) and Fgf2 -/- (Figure 6b ) mice show fewer trabeculae and loss of connectivity in the bones of Fgf2 -/-mice compared with Fgf2 +/+ mice. The micro-CT data (Table 3 ) and the static histomorphometric data (Table 4 ) from these 8-month-old mice demonstrate a more marked increase in trabecular separation, a further reduction in BV/TV and Tb.N and a decrease in Tb.Th. These data confirm the results observed in the 4.5-month-old Fgf2 -/-mice and further suggest that these changes are progressive as these mice age.
A decrease in the amount of bone and the number of trabeculae in the primary spongiosa could occur in Fgf2 -/-bones if cartilage maturation was delayed that resulted in low peak bone mass. However, the growth plates of these mice showed no gross abnormality (51) . We cannot rule out from the present studies the possibility that trabecular bone resorption was increased in Fgf2 -/-mice in the very early stage of trabecular bone development and declined rapidly as the animal grew. However, an alternate explanation for these results is that because bone mass and structure are determined by the balance of bone formed and resorbed during turnover, there could be a negative balance if the bone resorption rate is not altered but is still greater than the rate of bone formation.
Dynamic histomorphometry (Table 2) confirms that there is a significant decrease in DLS/BS, BFR/BS, and MAR in the bones of 4.5-month-old Fgf2 -/-mice. These results are further supported by the in vitro bone formation data (Figure 3, a and b) that demonstrate a marked decrease in ALP colonies, colony area, and mineralized nodule formation in bone marrow stromal cultures from Fgf2 -/-mice compared with Fgf2 +/+ . The decreased MAR is paradoxical, as several studies have shown that chronic FGF-2 treatment of osteoblastic cultures inhibited collagen synthesis, alkaline phosphatase activity, and osteocalcin synthesis (2). However, FGF-2 stimulates the proliferation of osteoblasts, and a number of in vitro and in vivo studies have shown that intermittent treatment with FGF-2 increases new bone formation (2, (25) (26) (27) (28) (29) (30) . This increase in new bone formation is only observed on the endosteal and trabecular bone surfaces. There is also increased newly formed cancellous bone filling the marrow spaces, suggesting that the target cells for this effect of FGF-2 are the osteoblast precursors present in the bone marrow. Thus, FGF-2 appears to inhibit the function of differentiated osteoblasts, whereas its anabolic action is probably due to an increase in the number of preosteoblasts that can then differentiate into mature osteoblasts capable of inducing new bone formation. Therefore, in the Fgf2 -/-mice, with fewer osteoblast precursors, the mature osteoblast population would also be reduced and hence MAR may be decreased by this mechanism.
In summary, our studies show that disruption of the Fgf2 gene in mice results in decreased osteoblast replication, decreased mineralized nodule formation in bone marrow cultures, and decreased new bone formation in vivo. These data are the first to demonstrate an 
Figure 6
Undecalcified sections of the distal femur of (a) an 8-month-old Fgf2 +/+ mouse and (b) a Fgf -/-mouse (dark-field illumination). Trabecular number is decreased in the secondary spongiosa of the Fgf2 -/-mouse.
important role for endogenous FGF-2 in maintaining bone mass, as well as bone formation. We believe that the observations in the bones of the 4.5-month-old Fgf2 -/-mice are significant and are more marked in the older 8-month-old animals. These data further suggest that redundancy of members of the FGF family cannot compensate to prevent bone loss when the Fgf2 gene is disrupted in mice.
